Objective: Despite the critical role of Magnetic Resonance Imaging (MRI) in the diagnosis of brain tumours, there are still many pitfalls in the exact grading of them, in particular, gliomas. In this regard, it was aimed to examine the potential of Transfer Learning (TL) and Machine Learning (ML) algorithms in the accurate grading of gliomas on MRI images.
Materials And Methods: Dataset has included four types of axial MRI images of glioma brain tumours with grades I-IV: T1-weighted, T2-weighted, FLAIR, and T1-weighted Contrast-Enhanced (T1-CE). Images were resized, normalized, and randomly split into training, validation, and test sets. ImageNet pre-trained Convolutional Neural Networks (CNNs) were utilized for feature extraction and classification, using Adam and SGD optimizers. Logistic Regression (LR) and Support Vector Machine (SVM) methods were also implemented for classification instead of Fully Connected (FC) layers taking advantage of features extracted by each CNN.
Results: Evaluation metrics were computed to find the model with the best performance, and the highest overall accuracy of 99.38% was achieved for the model containing an SVM classifier and features extracted by pre-trained VGG-16.
Discussion: It was demonstrated that developing Computer-aided Diagnosis (CAD) systems using pre-trained CNNs and classification algorithms is a functional approach to automatically specify the grade of glioma brain tumours in MRI images. Using these models is an excellent alternative to invasive methods and helps doctors diagnose more accurately before treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10334-022-01046-y | DOI Listing |
Acta Neuropathol Commun
January 2025
Institute of Cancer Research, London, UK.
Histone mutations (H3 K27M, H3 G34R/V) are molecular features defining subtypes of paediatric-type diffuse high-grade gliomas (HGG) (diffuse midline glioma (DMG), H3 K27-altered, diffuse hemispheric glioma (DHG), H3 G34-mutant). The WHO classification recognises in exceptional cases, these mutations co-occur. We report one such case of a 2-year-old female presenting with neurological symptoms; MRI imaging identified a brainstem lesion which was biopsied.
View Article and Find Full Text PDFActa Neuropathol Commun
January 2025
Department of Neuropathology, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, 1, rue Cabanis, F- 75014, Paris, France.
Med Oncol
January 2025
School of Biotechnology, Centurion University of Technology and Management, Jatni, Bhubaneswar, Odisha, 752050, India.
Gliomas are aggressive intracranial tumors of the central nervous system with a poor prognosis, high risk of recurrence, and low survival rates. Radiation, surgery, and chemotherapy are traditional cancer therapies. It is very challenging to accurately image and differentiate the malignancy grade of gliomas due to their heterogeneous and infiltrating nature and the obstruction of the blood-brain barrier.
View Article and Find Full Text PDFJ Biochem
January 2025
Department of Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Glutamate-rich WD40 repeat containing 1 (GRWD1) is a novel oncogene/oncoprotein that downregulates the p53 tumor suppressor protein through several mechanisms. One important mechanism involves binding of GRWD1 to RPL11, which competitively inhibits the RPL11-MDM2 interaction and releases RPL11-mediated suppression of MDM2 ubiquitin ligase activity toward p53. Here, we mined the TCGA (The Cancer Genome Atlas) database to gain in-depth insight into the clinical relevance of GRWD1.
View Article and Find Full Text PDFBackground And Purpose: Radiation induced image changes (IC) on MRI have been observed after proton therapy for brain tumours. This study aims to create predictive models, with and without taking into account patient variation, based on dose, linear energy transfer (LET) and periventricular zone (PVZ) in a national cohort of patients with glioma treated with pencil beam scanning (PBS).
Materials And Methods: A cohort of 87 consecutive patients with oligodendroglioma or astrocytoma (WHO grade 2-4) treated with PBS from January 2019 to December 2021 was included.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!